Press Releases

Quanterix to Release Second Quarter 2018 Financial Results and Host Conference Call on Wednesday, August 8, 2018

July 26, 2018

Quanterix’ Ultra-Sensitive Technology Creates Breakthroughs in Brain Health of Military and Veterans

July 23, 2018

New research advances the diagnosis of concussions and PTSD for those in the line of duty

Powering Precision Health Founder to Speak at MedCity CONVERGE

June 27, 2018

Kevin Hrusovsky Will Address Early Diagnosis Through Predictive Biomarkers at Executive Summit on July 11

EY Announces Kevin Hrusovsky, President, Chairman and Chief Executive Officer of Quanterix and Founder of Powering Precision Health as an Entrepreneur of the Year ® 2018 Award Finalist in the New England Region

June 15, 2018

Lexington, Mass.

Quanterix Corporation Releases Operating Results for First Quarter 2018

May 09, 2018

Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced financial results for the first quarter 2018.

Quanterix to Release First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018

Business Wire | May 02, 2018

Lexington, Mass.

Quanterix Marks Leadership in Accelerating Neurology Research with 100-Publication Milestone

Business Wire | April 27, 2018

LEXINGTON, Mass.--(BUSINESS WIRE)--

Quanterix to Present at Needham and Company’s 17th Annual Healthcare Conference

Business Wire | March 21, 2018

Lexington, Mass.

Quanterix Corporation and DestiNA Genomics to Collaborate in Effort to Transform microRNA Biomarker Detection

Business Wire | March 20, 2018

Collaboration offers potential for PCR-free microRNA biomarker detection with high-specificity and ultra-sensitivity

Quanterix Corporation Releases Operating Results for Fourth Quarter and Fiscal Year 2017

Business Wire | March 14, 2018

Revenue at high end of range previously provided Successful IPO completed in December 2017 Launch of SR-X in Q4, earlier than planned

List by Topic

Cardiology(2)

Immunology(3)

Infectious Disease(3)

Neurology(21)

Oncology(9)

Technology(7)

Latest Tweets

10.10.2019

Depression is very common among #Alzheimers patients according to @alzassociation. #WorldMentalHealthDay is a reminder of the need for holistic care that addresses physical and mental treatment. Depression resources are available here: https://bit.ly/33oXOY5

10.10.2019

1/3 of #MS patients have contemplated #suicide at some point in their disease (via @ClevelandClinic). #WorldMentalHealthDay reminds us of the link between physical and mental health and the role #mentalhealth care must play in the treatment process. https://cle.clinic/33jqqll

10.08.2019

Good morning from #NYC! Our CEO @KevinHrusovsky stopped by @Nasdaq to sit down with @LyanneAlfaro and discuss the driving factors behind the #precisionmedicine revolution in #healthcare. Watch it here: https://bit.ly/2OvBgQZ #QTRX #biomarkers

10.07.2019

Congratulations @UTAustin’s Drs. Kesler & Dr. Henneghan for winning our Accelerator Grant! Next stop, our state-of-the-art #biomarker lab where they'll use Simoa to advance their research on the neurotoxic effect of #chemotherapy on #breastcancer patients. http://bit.ly/2OiPZi8

10.01.2019

LGC Announce Launch of its Quanterix Simoa HD-X Automated Analyser; First Bioanalytical CRO in Europe to Offer HD-X Platform in a Regulated Environment https://www.lgcgroup.com/newsroom-and-blog/news-and-blog/lgc-first-cro-to-offer-hd-x-platform-in-regulated-environment/ … @LGCGroup @QuanterixSimoa More UK & Irish life science business news at [LSUK] https://www.life-sciences-uk.com/news/life-sciences-twitter-uk-united-kingdom-great-britain-gb-news-releases-england-wales-scotland-ireland-1001-777-10-0-2-desc.html … pic.twitter.com/sSvqLb2Hrz